Market revenue in 2023 | USD 1,575.7 million |
Market revenue in 2030 | USD 2,315.3 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.82% in 2023. Horizon Databook has segmented the North America implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
Developed markets such as Canada & the U.S. contribute to a significant demand for implantable cardioverter defibrillators ICDs owing to a supportive healthcare ecosystem & favorable reimbursement policy in the region.
Furthermore, the region has a significant prevalence of Cardiovascular Diseases (CVD), contributing to the need for ICDs. In addition, various studies indicated a correlation between patients having an ICD implant & incidence of hypertension.
According to Health and Stroke Foundation of Canada, one in four people in Canada suffers from hypertension. Hence, the significant prevalence of CVD, such as hypertension, aids the market growth. Furthermore, the regional market is supported by the presence of companies such as Medtronic, Abbott, and Boston Scientific Corporation.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into North America implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account